E. K. Weir

1.5k total citations
33 papers, 1.1k citations indexed

About

E. K. Weir is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Surgery. According to data from OpenAlex, E. K. Weir has authored 33 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pulmonary and Respiratory Medicine, 8 papers in Physiology and 7 papers in Surgery. Recurrent topics in E. K. Weir's work include Pulmonary Hypertension Research and Treatments (10 papers), Nitric Oxide and Endothelin Effects (7 papers) and Eicosanoids and Hypertension Pharmacology (5 papers). E. K. Weir is often cited by papers focused on Pulmonary Hypertension Research and Treatments (10 papers), Nitric Oxide and Endothelin Effects (7 papers) and Eicosanoids and Hypertension Pharmacology (5 papers). E. K. Weir collaborates with scholars based in United States, South Africa and Australia. E. K. Weir's co-authors include Stephen L. Archer, J. T. Reeves, Adam Tucker, Richard Dykoski, Jesse E. Edwards, Jürgen Ludwig, Brooks S. Edwards, William D. Edwards, R. F. Grover and Ivan F. McMurtry and has published in prestigious journals such as Journal of Clinical Investigation, Journal of the American College of Cardiology and The FASEB Journal.

In The Last Decade

E. K. Weir

32 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
E. K. Weir United States	15	409	327	315	245	243	33	1.1k
Masato Imai Japan	20	95 0.2×	105 0.3×	261 0.8×	109 0.4×	427 1.8×	34	1.7k
Atsumi Mori Japan	20	246 0.6×	129 0.4×	483 1.5×	114 0.5×	235 1.0×	66	1.6k
Mary E. Gray United States	21	943 2.3×	89 0.3×	539 1.7×	238 1.0×	569 2.3×	38	1.7k
Deborah U. Frank United States	18	490 1.2×	208 0.6×	844 2.7×	104 0.4×	411 1.7×	38	1.6k
Júlia Hoffmann Germany	20	632 1.5×	106 0.3×	265 0.8×	24 0.1×	257 1.1×	44	1.2k
Spencer I. Danto United States	20	646 1.6×	95 0.3×	723 2.3×	78 0.3×	211 0.9×	31	1.3k
M. F. Flessner United States	20	220 0.5×	65 0.2×	372 1.2×	54 0.2×	374 1.5×	25	1.5k
Olga Tura-Ceide Spain	22	489 1.2×	115 0.4×	532 1.7×	27 0.1×	185 0.8×	78	1.3k
Christian Kühn Germany	22	261 0.6×	167 0.5×	847 2.7×	75 0.3×	202 0.8×	65	1.9k
Marc S. Arkovitz United States	19	516 1.3×	131 0.4×	478 1.5×	39 0.2×	789 3.2×	41	1.4k

Countries citing papers authored by E. K. Weir

Since Specialization

Citations

This map shows the geographic impact of E. K. Weir's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. K. Weir with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. K. Weir more than expected).

Fields of papers citing papers by E. K. Weir

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. K. Weir. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. K. Weir. The network helps show where E. K. Weir may publish in the future.

Co-authorship network of co-authors of E. K. Weir

This figure shows the co-authorship network connecting the top 25 collaborators of E. K. Weir. A scholar is included among the top collaborators of E. K. Weir based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. K. Weir. E. K. Weir is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ross, John J., Zhigang Hong, Lepeng Zeng, et al.. (2007). Cytokine-induced differentiation of multipotent adult progenitor cells into functional smooth muscle cells. Journal of Clinical Investigation. 117(7). 2014–2014. 6 indexed citations

Ross, Jeffrey, Zhigang Hong, Lepeng Zeng, et al.. (2006). Cytokine-induced differentiation of multipotent adult progenitor cells into functional smooth muscle cells. Journal of Clinical Investigation. 116(12). 3139–3149. 134 indexed citations

Kelly, Rosemary F., Jozef Murar, Zhigang Hong, et al.. (2003). Low potassium dextran lung preservation solution reduces reactive oxygen species production. The Annals of Thoracic Surgery. 75(6). 1705–1710. 16 indexed citations

Weir, E. K., Stephen L. Archer, & John Τ. Reeves. (2000). The Fetal and Neonatal Pulmonary Circulations. Medical Entomology and Zoology. 17 indexed citations

Bartholomew, John R., et al.. (1996). Duplex Ultrasound Examination of the Acutely Painful and Swollen Leg. Dermatologic Surgery. 22(4). 383–387. 6 indexed citations

Weir, E. K. & Stephen L. Archer. (1995). The mechanism of acute hypoxic pulmonary vasoconstriction: the tale of two channels. The FASEB Journal. 9(2). 183–189. 370 indexed citations

Wyatt, Christopher N., E. K. Weir, & Chris Peers. (1994). Inhibition of Ionic Currents in Isolated Type I Cells of the Neonatal Rat Carotid Body By Diphenylene Iodonium. Journal of Bioresource Management. 2 indexed citations

Archer, Stephen L., Václav Hampl, Daniel Nelson, et al.. (1994). Role of Endothelial-Derived Nitric Oxide in Normal and Hypertensive Pulmonary Vasculature. Seminars in Respiratory and Critical Care Medicine. 15(3). 179–189. 10 indexed citations

Edwards, Brooks S., E. K. Weir, William D. Edwards, et al.. (1987). Coexistent pulmonary and portal hypertension: Morphologic and clinical features. Journal of the American College of Cardiology. 10(6). 1233–1238. 149 indexed citations

10.

Archer, Stephen L., Elliot Chesler, Jay N. Cohn, & E. K. Weir. (1986). ZK 36–374, a stable analog of prostacyclin, prevents acute hypoxic pulmonary hypertension in the dog. Journal of the American College of Cardiology. 8(5). 1189–1194. 10 indexed citations

11.

Archer, Stephen L., John W. Eaton, Elliot Chesler, & E. K. Weir. (1985). Nitrofurantoin reduces chronic hypoxic pulmonary hypertension in rats. Federation Proceedings. 44(5). 1 indexed citations

12.

Mahowald, Maren L., et al.. (1985). Pulmonary hypertension in systemic lupus erythematosus: effect of vasodilators on pulmonary hemodynamics.. PubMed. 12(4). 773–7. 14 indexed citations

13.

Weir, E. K., et al.. (1983). Diamide Inhibits Pulmonary Vasoconstriction Induced by Hypoxia or Prostaglandin F2 . Experimental Biology and Medicine. 173(1). 96–103. 14 indexed citations

14.

Will, J. A., et al.. (1982). Oxidants cause pulmonary vasodilation. 18(4). 1 indexed citations

15.

Weir, E. K., et al.. (1981). Diagnosis of aortic stenosis in older age groups using external carotid pulse recording and phonocardiography.. Heart. 45(5). 577–582. 21 indexed citations

16.

Weir, E. K., D. H. Will, A. F. Alexander, et al.. (1979). Vascular hypertrophy in cattle susceptible to hypoxic pulmonary hypertension. Journal of Applied Physiology. 46(3). 517–521. 17 indexed citations

17.

Doekel, Robert C., et al.. (1978). Potentiation of hypoxic pulmonary vasoconstriction by ethyl alcohol in dogs. Journal of Applied Physiology. 44(1). 76–80. 27 indexed citations

18.

Tucker, Alan, Eric A. Hoffman, & E. K. Weir. (1977). Histamine Receptor Antagonism Does Not Inhibit Hypoxic Pulmonary Vasoconstriction in Dogs. CHEST Journal. 71(2). 261–262. 5 indexed citations

19.

Mlczoch, J, E. K. Weir, & Robert F. Grover. (1977). Inhibition of hypoxic pulmonary vasoconstriction by dipyridamole is not platelet mediated. Canadian Journal of Physiology and Pharmacology. 55(3). 448–451. 12 indexed citations

20.

Weir, E. K., Ivan F. McMurtry, Adam Tucker, J. T. Reeves, & R. F. Grover. (1976). Prostaglandin synthetase inhibitors do not decrease hypoxic pulmonary vasoconstriction. Journal of Applied Physiology. 41(5). 714–718. 78 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact